<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">25078106</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>03</Month>
            <Day>30</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1475-2840</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>13</Volume>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jul</Month>
                        <Day>31</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cardiovascular diabetology</Title>
                <ISOAbbreviation>Cardiovasc Diabetol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>GLP-1 (7-36) amide restores myocardial insulin sensitivity and prevents the progression of heart failure in senescent beagles.</ArticleTitle>
            <Pagination>
                <MedlinePgn>115</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12933-014-0115-x</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We previously demonstrated that older beagles have impaired whole body and myocardial insulin responsiveness (MIR), and that glucagon-like peptide-1 (GLP-1 [7-36] amide) improves MIR in young beagles with dilated cardiomyopathy (DCM). Here, we sought to determine if aging alone predisposes to an accelerated course of DCM, and if GLP-1 [7-36] amide would restore MIR and impact the course of DCM in older beagles.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Eight young beagles (Young-Control) and sixteen old beagles underwent chronic left ventricle (LV) instrumentation. Seven old beagles were treated with GLP-1 (7-36) amide (2.5 pmol/kg/min) for 2 weeks prior to instrumentation and for 35 days thereafter (Old + GLP-1), while other 9 served as control (Old-Control). All dogs underwent baseline metabolic determinations and LV biopsy for mitochondria isolation prior to the development of DCM induced by rapid pacing (240 min-1). Hemodynamic measurements were performed routinely as heart failure progressed.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">At baseline, all old beagles had elevated non-esterifed fatty acids (NEFA), and impaired MIR. GLP-1 reduced plasma NEFA (Old-Control: 853 ± 34; Old + GLP-1: 531 ± 33 μmol/L, p &lt; 0.02), improved MIR (Old-Control: 289 ± 54; Old + GLP-1: 512 ± 44 mg/min/100 mg, p &lt; 0.05), and increased uncoupling protein-3 (UCP-3) expression in isolated mitochondria. Compared to the Young-Control, the Old-Controls experienced an accelerated course of DCM (7 days versus 29 days, p &lt; 0.005) and excess mortality, while the Old + GLP-1 experienced increased latency to the onset of DCM (7 days versus 23 days, p &lt; 0.005) and reduced mortality.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Aging is associated with myocardial insulin resistance, which predispose to an accelerated course of DCM. GLP-1 treatment is associated with increased MIR and protection against an accelerated course of DCM in older beagles.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Melissa</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Angeli</LastName>
                    <ForeName>Franca S</ForeName>
                    <Initials>FS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shen</LastName>
                    <ForeName>You-Tang</ForeName>
                    <Initials>YT</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shannon</LastName>
                    <ForeName>Richard P</ForeName>
                    <Initials>RP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. rs3mt@virginia.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 AG023125</GrantID>
                    <Acronym>AG</Acronym>
                    <Agency>NIA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 AG 023125</GrantID>
                    <Acronym>AG</Acronym>
                    <Agency>NIA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Cardiovasc Diabetol</MedlineTA>
            <NlmUniqueID>101147637</NlmUniqueID>
            <ISSNLinking>1475-2840</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D002316">Cardiotonic Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>119637-73-9</RegistryNumber>
                <NameOfSubstance UI="C055453">glucagon-like peptide 1 (7-36)amide</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>89750-14-1</RegistryNumber>
                <NameOfSubstance UI="D052216">Glucagon-Like Peptide 1</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002316" MajorTopicYN="N">Cardiotonic Agents</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D052216" MajorTopicYN="N">Glucagon-Like Peptide 1</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007333" MajorTopicYN="N">Insulin Resistance</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>05</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>3</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25078106</ArticleId>
            <ArticleId IdType="pii">s12933-014-0115-x</ArticleId>
            <ArticleId IdType="doi">10.1186/s12933-014-0115-x</ArticleId>
            <ArticleId IdType="pmc">PMC4149213</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Physiol. 2000 Jul 1;526 Pt 1:203-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10878112</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care Med. 2014 Mar;42(3):638-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24247476</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Physiol Pharmacol. 2000 Dec;51(4 Pt 2):871-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11220495</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Cell Cardiol. 2001 Jun;33(6):1065-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11444914</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2002 Jul;110(1):43-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12093887</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2002 Aug 15;418(6899):797-801</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12181572</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2003 May 16;300(5622):1140-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12750520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Heart Fail. 2003 Aug;5(4):427-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12921803</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cardiovasc Res. 2004 Feb 1;61(2):297-306</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14736546</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 2004 Aug 24;110(8):955-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15313949</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">388439</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Enzymol. 1990;186:407-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2233308</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 1993 Jul;88(1):107-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8319323</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):6A-13A</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8376698</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol. 1994 Mar;266(3 Pt 1):E459-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8166268</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Geriatr Soc. 1997 Aug;45(8):968-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9256850</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biochem. 1997 Sep;174(1-2):305-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9309704</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Regul Pept. 2005 Feb 15;125(1-3):173-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15582729</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Exp Ther. 2005 Jan;312(1):303-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15356213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cardiovasc Res. 2005 May 1;66(2):222-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15820191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Metab. 2005 Aug;2(2):85-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16098826</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2401-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16024574</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2005 Dec;115(12):3587-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16284649</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18769-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16365283</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 2007 Aug 21;116(8):901-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17679614</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Cardiol. 2007 Sep 1;100(5):824-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17719327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Heart Circ Physiol. 2007 Nov;293(5):H3063-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17873028</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Physiol Rev. 2008 Apr;88(2):581-609</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18391174</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Biochem Biophys. 2008 Oct 15;478(2):136-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18708025</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta. 2009 Oct;1790(10):1059-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19371772</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circ Heart Fail. 2010 Jul;3(4):512-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20466848</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cardiovasc Res. 2011 May 1;90(2):202-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21289012</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2013 Oct 3;369(14):1317-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23992601</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cardiovasc Diabetol. 2013;12:148</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24125539</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cardiovasc Diabetol. 2013;12:154</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24148218</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Physiol. 2000 Jul 1;526 Pt 1:211-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10878113</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>